SUBSCRIBE
SUBSCRIBE

Nick Paul Taylor

Nick is a freelance writer who has been reporting on the global life sciences industry since 2008. With a BSc in biology, Nick writes about the science and business of biopharma and medtech for numerous healthcare publications. He can be reached at nick.paul.taylor@gmail.com or on LinkedIn.

Composite photo collage of hand hold magnifier glass research examine secret object question mark secret isolated on painted background.
Manufacturing
FDA pilots AI-informed one-day facility inspections
Implemented as part of a broader initiative to make more targeted and efficient use of inspection resources, the pilot program will use artificial intelligence to enable shorter, focused screenings to complement standard FDA inspections.
May 7, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Community expansion. Collaboration, of new members. Cooperate on project development. Find like-minded people, join the team. Spread influence and power.
Manufacturing
Amgen, Sanofi commit nearly $600M to North American expansions
Sanofi’s investment will support a Canadian site’s efforts to apply AI to drug production, while Amgen has unveiled the second expansion of its Puerto Rico plant in quick succession.
May 6, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Factory closed with disappointed worker doodle cartoon illustration. Industrial shutdown. Layoff in manufacturing plant closure 2D flat character isolated on white. Doodleart hand-drawn drawing
Layoffs
BioNTech moves to close multiple manufacturing plants, affecting 1,860 jobs
The action affects BioNTech sites in Germany and Singapore, where the company expects to have excess capacity.
May 5, 2026
 · 
2 min read
 · 
Nick Paul Taylor
pills Medicine tablet in blister pack on a yellow background
Manufacturing
Sertraline manufacturer recalls antidepressant batch after UK packaging mix-up
A subsidiary of Indian drugmaker Hetero Group mistakenly packaged two types of antidepressants in packs of sertraline, potentially posing risks to patients.
May 5, 2026
 · 
2 min read
 · 
Nick Paul Taylor
pharmaceutical industry, medicine pills are filling in the bottle on production line machine conveyor at the medical factory. selective focus.
Manufacturing
PCI adds US sterile fill/finish capabilities through $1B global expansion drive
Amid disruption to the outsourced fill/finish market, PCI is investing $100 million to more than double the capacity to fill ready-to-use prefilled syringes and cartridges at its San Diego campus.
May 4, 2026
 · 
2 min read
 · 
Nick Paul Taylor
A surreal concept of a regular aluminium ladder pushing through a fluffy cloud on a peach sky background - 3D render
Obesity
Obesity ends oncology’s long reign as top contributor to biopharma pipeline value
In its latest biopharma pipeline report, Deloitte warned that the growing importance of a small pool of potential mega-blockbusters raises the risk of “significant value destruction from a single program failure.”
May 4, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Photo of pinned Raleigh on a map of USA. May be used as illustration for traveling theme.
Manufacturing
Novartis unveils North Carolina API plant as final piece of $23B US expansion
The new plant will give Novartis end-to-end capabilities centered on North Carolina, where it plans to have five facilities across three sites.
May 1, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Isolated vector design.
Neurodegenerative disease
Corcept ties ALS drug to improved 2-year survival as Phase 3 start date nears
Corcept Therapeutics’ amyotrophic lateral sclerosis drug was linked to an 87% reduction in the risk of death, a result the biotech hopes to replicate in an upcoming Phase 3 trial.
May 1, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Shanghai,China-August 24th 2025: AstraZeneca company office building
Earnings
AstraZeneca bullish on $80B sales goal after beating expectations, Phase 3 data wins
After a quarter in which sales topped $15 billion and key readouts went AstraZeneca’s way, the company is increasingly confident that its 2030 revenue target is in reach.
April 29, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Recovering losses, effective economic measures to help alleviate inflation or economic crisis resulting in the collapse of the business economy or stock market, helping hands to catch gold coins rolling down a tilted cliff
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
The settlements delay the entry of generic copies of Pfizer’s Vyndamax by almost three years, stabilizing sales of a drug that generated $3.8 billion in the U.S. last year.
April 29, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Sanofi CEO Belén Garijo
C-suite
Garijo starts as Sanofi CEO with window to ease reliance on Dupixent
The new CEO has at least five years and a large M&A war chest to position Sanofi for life after the loss of exclusivity on its cornerstone immunology product.
April 28, 2026
 · 
4 min read
 · 
Nick Paul Taylor
scientists couple holding barrels with warning sign african american man woman in protective suits working with chemicals research science concept modern laboratory interior full length horizontal vector illustration..
Manufacturing
UCSF, Par Health hit with FDA warning letters for environmental monitoring issues
FDA inspectors warned UCSF radiopharmaceutical facility that losing environmental control could pose a serious hazard to patients.
April 27, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Illustration of two arrows merging into one
Deals
Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership
The takeover will give Amneal control of four facilities to manufacture biosimilars for a planned wave of launches in the coming years.
April 23, 2026
 · 
2 min read
 · 
Nick Paul Taylor
USA Map with red pins featuring the Carolinas, specifically Raleigh Durham. Could be used to showcase store locations or represent many locations.
Manufacturing
AbbVie commits $1.4B to NC plant in its largest-ever single campus investment
The Durham plant will manufacture immunology, neuroscience and oncology drugs once AbbVie finishes construction in 2028.
April 23, 2026
 · 
2 min read
 · 
Nick Paul Taylor
3D Yellow triangle warning sign symbol on yellow background. Emergency alert, and caution. Illustration with copy space
Manufacturing
FDA issues warning letter after GLP-1 manufacturer refuses inspectors access
New Life told FDA inspectors that they lacked the authority to enter parts of a facility where it made the GLP-1 receptor agonists semaglutide and tirzepatide.
April 22, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Load More